ST
EBS icon

Smithfield Trust’s Emergent Biosolutions EBS Stock Holding History

Smithfield Trust’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-90
Closed -$5K – 1079
2021
Q3 		$5K Hold
90
– – ﹤0.01% 1002
2021
Q2 		$6K Sell
90
-908
-91% -$58.3K ﹤0.01% 945
2021
Q1 		$92K Sell
998
-32
-3% -$3.28K 0.01% 454
2020
Q4 		$92K Buy
1,030
+94
+10% +$8.63K 0.01% 439
2020
Q3 		$96K Sell
936
-232
-20% -$25K 0.01% 401
2020
Q2 		$92K Sell
1,168
-142
-11% -$10.6K 0.01% 398
2020
Q1 		$76K Sell
1,310
-182
-12% -$10.5K 0.01% 377
2019
Q4 		$80K Sell
1,492
-430
-22% -$23.3K 0.01% 443
2019
Q3 		$100K Sell
1,922
-962
-33% -$44.8K 0.01% 393
2019
Q2 		$139K Buy
2,884
+72
+3% +$3.45K 0.01% 332
2019
Q1 		$142K Buy
2,812
+366
+15% +$21.6K 0.02% 311
2018
Q4 		$145K Buy
2,446
+1,790
+273% +$115K 0.02% 283
2018
Q3 		$43K Hold
656
– – ﹤0.01% 550
2018
Q2 		$33K Sell
656
-28
-4% -$1.46K ﹤0.01% 592
2018
Q1 		$36K Buy
684
+664
+3,320% +$33.1K ﹤0.01% 551
2017
Q4 		$1K Buy
+20
New +$842 ﹤0.01% 1083

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Smithfield Trust's EBS Position: Q4 2021 in Review

Smithfield Trust sold out of Emergent Biosolutions (EBS) in Q4 2021, closing a stake of 90 shares — an estimated $5K sold.

Smithfield Trust first reported a position in EBS in Q4 2017 and held it in 16 quarters. The position peaked at $145K in Q4 2018. 254 funds tracked by Wall St. Rank hold EBS as of Q4 2021.

  • Smithfield Trust reported no remaining Emergent Biosolutions position as of Q4 2021 after selling out during the quarter.
  • Smithfield Trust sold 90 Emergent Biosolutions shares in Q4 2021, an estimated $5K.
  • Smithfield Trust first reported a position in Emergent Biosolutions in Q4 2017 and held it in 16 quarters.
  • Smithfield Trust's Emergent Biosolutions position peaked at $145K in Q4 2018.
  • 254 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2021.

Based on Smithfield Trust's 13F filing for Q4 2021, filed 14 Feb 2022.